R Keul
Overview
Explore the profile of R Keul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muller-Newen G, Kuster A, Hemmann U, Keul R, Horsten U, Martens A, et al.
J Immunol
. 1998 Dec;
161(11):6347-55.
PMID: 9834125
Soluble receptors for several cytokines have been detected in body fluids and are believed to modulate the cytokine response by binding the ligand and thereby reducing its bioavailability. In the...
2.
Keul R, Heinrich P, Muller-Newen G, Muller K, Woo P
Cytokine
. 1998 Oct;
10(9):729-34.
PMID: 9770335
Investigation of the agonist and two antagonists to interleukin 6 (IL-6) and their possible role in the pathogenesis of different sub-groups of juvenile chronic arthritis (JCA). Sera of 54 patients...
3.
Muller-Newen G, Kohne C, Keul R, Hemmann U, Muller-Esterl W, Wijdenes J, et al.
Eur J Biochem
. 1996 Mar;
236(3):837-42.
PMID: 8665902
The soluble human interleukin-6 receptor (shIL6R) was purified from human plasma. In a single immunoaffinity purification step a 140000-fold enrichment with a yield of 95% was achieved. A subsequent IL-6...
4.
Keul R, Roth M, Papakonstantinou E, Nauck M, Perruchoud A, BLOCK L
Thorax
. 1996 Feb;
51(2):150-4.
PMID: 8711646
Background: Broncho-Vaxom (OM-85 BV) increases the resistance of the respiratory tract to bacterial infections by modulating host immune responses. The compound increases serum IgG levels but decreases IgE levels in...
5.
BLOCK L, Keul R, Crabos M, Ziesche R, Roth M
Proc Natl Acad Sci U S A
. 1993 May;
90(9):4097-101.
PMID: 7683421
The pharmacological potency of angiotensin-converting enzyme (ACE) inhibitors (lisinopril and enalaprilat) on the transcription of low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase genes was examined in human vascular smooth muscle...
6.
Roth M, Keul R, Perruchoud A, BLOCK L
Am Heart J
. 1993 Feb;
125(2 Pt 2):598-603.
PMID: 8430604
The effects of manidipine, a newly developed Ca2+ channel blocker, on recombinant platelet-derived growth factor BB (rPDGF-BB)-induced transcription of the low-density lipoprotein receptor and the 3-hydroxy-3-methylglutaryl coenzyme A reductase genes...
7.
Roth M, Keul R, EMMONS L, Horl W, BLOCK L
Proc Natl Acad Sci U S A
. 1992 May;
89(9):4071-5.
PMID: 1570335
Manidipine, a Ca(2+)-channel blocker, at concentrations that lower elevated blood pressure, modulates the transcription rates of cytokine genes in the mesangial cells of humans that had been stimulated with platelet-derived...